Pharma News India

The Indian pharma company will review the capex requirement at the end of the next quarter.

Hyderabad, November 18, 2014: The Indian drug firm Aurobindo Pharma may spend Rs 1,300 crore towards capex during the ongoing and the next financial year. The company is expecting to spend close to Rs 600 crore towards capex this year and will review the requirement at the end of the next ...


Temasek has acquired a 10.6 per cent equity stake in Intas.

New Delhi, November 11, 2014: Intas Pharmaceuticals Ltd has announced that the Singapore based investment firm, Temasek, has acquired a 10.6 per cent stake in the company by secondary purchase of shares from ChrysCapital.


The vaccine has been developed and manufactured by its India affiliate Shantha.

Hyderabad, November 10, 2014: Sanofi Pastuer has introduced the paediatric pentavent vaccine, Shan5. The vaccine has been developed and manufactured by its affiliate Shantha. It may be noted here that Shantha is a fully integrated biotechnology company involved in R and D, manufacturing and marketing,...


The company is looking at inorganic growth options in order to bolster its overseas presence.

New Delhi, October 29, 2014: With a view to increase its overseas presence, the Indian drug major Lupin is looking at acquisitions in the US, mainly in the inhalers and injectables segment. The company continues to evaluate opportunities and the acquisitions in the US with a view to ...


Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets

New Delhi, October 21, 2014: Natco Pharma's marketing partner in the US, Breckenridge Pharmaceutical Inc, has received a tentative approval from the US health regulator for its generic Armodafinil tablets. These tablets are used for improving wakeful...


Comment!

 
 






* Indicates mandatory field.
Please wait while comments are being sent...